Human papillomavirus infection in Bhutan at the moment of implementation of a national HPV vaccination programme

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Tshomo, Ugyen ^a   Franceschi, Silvia ^b   Dorji, Dorji ^a   Baussano, Iacopo ^b   Tenet, Vanessa ^b   Snijders, Peter J F ^c   Meijer, Chris J L M ^c   Bleeker, Maaike C G ^c   Gheit, Tarik ^b   Tommasino, Massimo ^b   Clifford, Gary M ^b  

^a Royal Government of Bhutan   (Bhutan)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bhutan; Cervical cancer; Human papillomavirus; Prevalence

Indexed keywords

ADULT; AGE; AGE DISTRIBUTION; AGED; ARTICLE; BHUTAN; FEMALE; HEALTH PROGRAM; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN TISSUE; MAJOR CLINICAL STUDY; MARRIAGE; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; SEXUAL BEHAVIOR; UTERINE CERVIX CARCINOMA IN SITU; VACCINATION;

ADOLESCENT; ADULT; AGED; BHUTAN; FEMALE; HUMANS; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PREVALENCE; UTERINE CERVICAL NEOPLASMS; VACCINATION; YOUNG ADULT;

EID: 84904522945     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-408     Document Type: Article

References (24)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worlwide: IARC CancerBase No. 11 [Internet] 2013, Lyon, France: International Agency for Research on Cancer.
2. World Cancer Report 2014 2014, Lyon, France: International Agency for Research on Cancer, Steward BW, Wild CP.
3. Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjose S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ, Franceschi S, . and the IARC HPV Prevalence Surveys Study Group Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005, 366:991-998. 10.1016/S0140-6736(05)67069-9, 16168781, and the IARC HPV Prevalence Surveys Study Group.
4. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, Young N. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002, 287:2114-2119. 10.1001/jama.287.16.2114, 11966386.
5. Roda Husman AM, Snijders PJ, Stel HV, van den Brule AJ, Meijer CJ, Walboomers JM. Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction. Br J Cancer 1995, 72:412-417. 10.1038/bjc.1995.347, 2033993, 7543772.
6. Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N, Meijer CJ. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 2000, 87:221-227. 10.1002/1097-0215(20000715)87:2<221::AID-IJC11>3.0.CO;2-2, 10861478.
7. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002, 40:779-787. 10.1128/JCM.40.3.779-787.2002, 120256, 11880393.
8. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 90: Human Papillomaviruses [90] 2007, 1-670. Lyon: International Agency for Research on Cancer. Monographs on the Evaluation of carcinogenic Risk to Humans, IARC.
9. Gheit T, Tommasino M. Detection of high-risk mucosal human papillomavirus DNA in human specimens by a novel and sensitive multiplex PCR method combined with DNA microarray. Methods Mol Biol 2011, 665:195-212.
10. Eklund C, Zhou T, Dillner J. Global proficiency study of human papillomavirus genotyping. J Clin Microbiol 2010, 48:4147-4155. 10.1128/JCM.00918-10, 3020877, 20844222.
11. Gheit T, Landi S, Gemignani F, Snijders PJ, Vaccarella S, Franceschi S, Canzian F, Tommasino M. Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. J Clin Microbiol 2006, 44:2025-2031. 10.1128/JCM.02305-05, 1489390, 16757593.
12. Keita N, Clifford GM, Koulibaly M, Douno K, Kabba I, Haba M, Sylla BS, van Kemenade FJ, Snijders PJ, Meijer CJ, Franceschi S. HPV infection in women with and without cervical cancer in Conakry, Guinea. Br J Cancer 2009, 101:202-208. 10.1038/sj.bjc.6605140, 2713688, 19536089.
13. Dondog B, Clifford GM, Vaccarella S, Waterboer T, Unurjargal D, Avirmed D, Enkhtuya S, Kommoss F, Wentzensen N, Snijders PJ, Meijer CJ, Franceschi S, Pawlita M. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study. Cancer Epidemiol Biomarkers Prev 2008, 17:1731-1738. 10.1158/1055-9965.EPI-07-2796, 18628425.
14. Thomas JO, Herrero R, Omigbodun AA, Ojemakinde K, Ajayi IO, Fawole A, Oladepo O, Smith JS, Arslan A, Muñoz N, Snijders PJ, Meijer CJ, Franceschi S. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer 2004, 90:638-645. 10.1038/sj.bjc.6601515, 2409602, 14760378.
15. Aruhuri B, Tarivonda L, Tenet V, Sinha R, Snijders PJ, Clifford G, Pang J, McAdam M, Meijer CJ, Frazer IH, Franceschi S. Prevalence of Cervical Human Papillomavirus (HPV) Infection in Vanuatu. Cancer Prev Res (Phila) 2012, 5:746-753. 10.1158/1940-6207.CAPR-11-0515, 22427345.
16. Franceschi S, Rajkumar R, Snijders PJF, Arslan A, Mahé C, Plummer M, Sankaranarayanan R, Cherian J, Meijer CJLM, Weiderpass E. Papillomavirus infection in rural women in southern India. Br J Cancer 2005, 92:601-606. 2362069, 15668709.
17. Dai M, Bao YP, Li N, Clifford GM, Vaccarella S, Snijders PJF, Huang RD, Sun LX, Meijer CJLM, Qiao YL, Franceschi S. Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer 2006, 95:96-101. 10.1038/sj.bjc.6603208, 2360486, 16773069.
18. Wu RF, Dai M, Qiao YL, Clifford GM, Liu ZH, Arslan A, Li N, Shi JF, Snijders PJ, Meijer CJ, Franceschi S. Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisation. Int J Cancer 2007, 121:1306-1311. 10.1002/ijc.22726, 17417776.
19. Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer 2011, 128:927-935. 10.1002/ijc.25396, 20473886.
20. Sherpa AT, Clifford GM, Vaccarella S, Shrestha S, Nygård M, Karki BS, Snijders PJ, Meijer CJ, Franceschi S. Human papillomavirus infection in women with and without cervical cancer in Nepal. Cancer Causes Control 2010, 21:323-330. 10.1007/s10552-009-9467-z, 20217467.
21. Maucort-Boulch D, Franceschi S, Plummer M. International correlation between human papillomavirus prevalence and cervical cancer incidence. Cancer Epidemiol Biomarkers Prev 2008, 17:717-720. 10.1158/1055-9965.EPI-07-2691, 18349293.
22. Guan P, Howell-Jones R, Li N, Bruni L, de Sanjose S, Franceschi S, Clifford GM. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer 2012, 131:2349-2359. 10.1002/ijc.27485, 22323075.
23. Vaccarella S, Herrero R, Dai M, Snijders PJ, Meijer CJ, Thomas JO, Hoang Anh PT, Ferreccio C, Matos E, Posso H, de Sanjose S, Shin HR, Sukvirach S, Lazcano-Ponce E, Ronco G, Rajkumar R, Qiao YL, Muñoz N, Franceschi S. Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys. Cancer Epidemiol Biomarkers Prev 2006, 15:2148-2153. 10.1158/1055-9965.EPI-06-0556, 17119039.
24. Vaccarella S, Franceschi S, Herrero R, Muñoz N, Snijders PJF, Clifford GM, Smith JS, Lazcano-Ponce E, Sukvirach S, Shin HR, de Sanjose S, Molano M, Matos E, Ferreccio C, Anh PTH, Thomas JO, Meijer CJLM, . and the IARC HPV Prevalence Surveys Study Group Sexual behavior, condom use and HPV: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev 2006, 15:326-333. 10.1158/1055-9965.EPI-05-0577, 16492924, and the IARC HPV Prevalence Surveys Study Group.